Early Screening and Identification for Panvascular Diseases
Sponsor
Beijing Tiantan Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05485870
Collaborator
Beijing Hospital (Other)
1,000
1
30
33.3
Study Details
Study Description
Brief Summary
Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis by a multi-omics study.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Early Screening and Identification for Panvascular Diseases
Actual Study Start Date
:
Jul 1, 2022
Anticipated Primary Completion Date
:
Jul 31, 2024
Anticipated Study Completion Date
:
Dec 31, 2024
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Panvascular disease group patients with panvascular diseases |
|
| Healthy controls Healthy controls |
Outcome Measures
Primary Outcome Measures
- Any new stroke events [Up to 48 months]
Incidence of any new ischemic or hemorrhagic stroke
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
- Patients with panvascular diseases; 2. Patients or guardians who agreed to join the study; 3. Patients who can complete the relevant examinations involved in this study;
Exclusion Criteria:
- patients with coagulation dysfunction.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Beijing Tiantan Hospital Capital Medical University | Beijing | Beijing | China | 100000 |
Sponsors and Collaborators
- Beijing Tiantan Hospital
- Beijing Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Beijing Tiantan Hospital
ClinicalTrials.gov Identifier:
NCT05485870
Other Study ID Numbers:
- 2021YFC2500502
First Posted:
Aug 3, 2022
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No